-+ 0.00%
-+ 0.00%
-+ 0.00%
Psyence BioMed names John Thorne project lead at new Texas ibogaine unit TIRC
Share
Listen to the news
Psyence BioMed names John Thorne project lead at new Texas ibogaine unit TIRC
  • Psyence Biomedical formed Texas Ibogaine Research Corporation as a dedicated U.S. vehicle for its ibogaine development program.
  • CEO Jody Aufrichtig will also serve as CEO of the new Texas entity.
  • Dr. John Thorne was appointed project lead for the Texas ibogaine initiative.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Psyence Biomedical Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609140700PRIMZONEFULLFEED9825717) on September 14, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending